Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic industry.
Our coverage of the US glaucoma surgery market includes a quarterly surveying process that targets and collects data from glaucoma surgeons. The resulting data are analyzed and presented in our US Glaucoma Surgery Quarterly Updates. These updates are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including a variety of vital practice of medicine issues, doctors’ evaluations of pharmaceuticals and surgical equipment, product use and market share, product adoption plans, and the identification of significant trends in the marketplace for the treatment of glaucoma.
Each update includes full-year forecasts, comparisons with prior years, and trend analysis.
The 2021 Glaucoma Pharmaceuticals Market Report is Market Scope’s comprehensive analysis of the glaucoma pharmaceuticals segment of ophthalmology. Our report is designed for members of the ophthalmic industry who participate in this market or are weighing doing so, market analysts, ophthalmologists who treat glaucoma patients, investors, and anyone else who might be interested in the global marketplace of glaucoma pharmaceuticals.
Market Scope’s 2020 European Five Ophthalmic Market Report analyzes the ophthalmic market in Western Europe’s five largest economies, discussing important trends and key factors for future success in 10 ophthalmic submarkets. The report includes forecasts of disease prevalence, numbers of treatments, and technologies used in treatments. It profiles ophthalmic companies in the five markets, provides analysis of current markets, and offers five-year forecasts of market performance.
The 2020 Glaucoma Surgical Device Market Report offers a comprehensive analysis of the 2020 global market for glaucoma devices, as well as a discussion of important trends and key factors shaping future success. The report covers prevalence and forecasts for glaucoma worldwide and discusses the ophthalmologists who treat glaucoma. It also examines the role of surgical intervention, the market dynamics for currently commercialized products, and the pipeline of investigational devices that may offer improved outcomes. Product demand is forecast in units and dollars, and market shares are analyzed by product category.
The “2020 China Ophthalmic Market Report” is the leading industry source for information on all aspects of the Chinese ophthalmic market. Our report includes a comprehensive overview of the Chinese population and economic conditions. We cover prevalence of and forecasts for eye diseases and conditions and discuss therapeutic approaches, including commercialized and pipeline products. We analyze unit demand and revenue and forecast future performance over the next five years. We also include market share data and discuss key strategic issues.
The 2020 India Ophthalmic Market Report analyzes the current landscape of the Indian ophthalmic market, discussing important trends and key factors for future success, and includes forecasts of disease prevalence, numbers of treatments, and technologies used in treatments.
The United States Glaucoma Atlas provides a geographic analysis of the glaucoma population and treatment opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis analyzes market potential and provides a benchmark against other atlas metros. The Glaucoma Atlas offers strategic insights into the top potential markets in the US.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.